scherichia coli is typically considered a harmless commensal bacteria colonizing the mammalian intestine. However, infection by numerous strains from the B2 phylogroup can cause septicemia/bacteremia, urinary tract infection, and meningitis and are increasingly being linked to inflammatory bowel disease and colorectal tumors in humans (1) (2) (3) . These strains commonly harbor an~54-kb polyketide synthetase (PKS) pathogenicity island that produces a genotoxin called colibactin (4, 5) . Recently, colibactin expression by the mouse commensal E. coli strain NC101 was shown to potentiate colitis-associated colorectal cancer in IL-10 Ϫ/Ϫ mice (2). Furthermore, aside from causing doublestrand DNA breaks, colibactin facilitates intestinal colonization and systemic translocation that causes septicemia and meningitis (6) . Thus, the virulence and oncogenic modalities of colibactinproducing E. coli strains in experimental mice may represent a potential confounder of results, especially in models of inflammatory disease and cancer.
In this report, we announce the draft genomes of five novel B2-phylotype E. coli strains isolated from the feces of two asymptomatic surveillance mice, the uterine fluid of a transgenic mouse, and from the blood of two experimental immunocompromised mice with sepsis housed under specific-pathogen-free conditions. We previously found all these strains except A4 were PCR-positive for the PKS genes clbA and clbQ and caused megalocytosis and ␥-H2AX-detectable DNA damage in HeLa cells in vitro, suggesting colibactin activity by these organisms ( [7] ; our unpublished data). We briefly describe the features of these novel E. coli genomes in context to the previously sequenced genomes of NC101 and the PKS-containing septicemia-and meningitis-causing strains IHE3034 and A192PP (4, 6) .
Genomes were sequenced using PacBio RSII and resulting sequencing data were assembled into two to five contigs using RS_ HGAP_Assembly.3 from the SMRT Portal 2.3. Contigs were annotated using the RAST tool kit (RASTtk) (8) . Novel strains have genomic sizes, GϩC content, protein-coding sequences, and RNAs comparable to those of the genomes of NC101 (GenBank: NZ_AEFA00000000.1), IHE3034 (GenBank: NC_017628.1), and A192PP (GenBank: NZ_CVOH00000000.1) ( Table 1 ). All novel genomes except A4 contained complete PKS islands, with all genes having Ն99% sequence identity and coverage as well as identical synteny to those from NC101, IHE3034, and A192PP.
PATRIC's proteome comparison service was used to determine the number of homologous genes between NC101, IHE3034, and A192PP as references versus the novel E. coli strains (9) . NC101 and the novel PKS-containing strains shared Ͼ4,780 proteins (Ͼ97%) as homologs, whereas between NC101 and A4, 4,732 proteins (~89%) were homologous. All novel E. coli strain shared considerably less homologs to IHE3034 (4,386 to 4,525 proteins; 87 to 90%) and A192PP (4,472 to 4,624;~80 to 83%). Aside from PKS, the virulence factors enterobactin sidero- Together, these genomic data suggest that the novel PKScontaining strains are more similar to NC101 than IHE3034 and A192PP. Future studies will investigate the pathogenic and carcinogenic potential of these and other PKS-containing E. coli strains in mice under differing experimental protocols. Accession number(s). The genome sequences have been submitted to GenBank under the accession numbers listed in Table 1 .
